Publication

Real-World eligibility for dapagliflozin in unselected heart failure patients: Data from the CORDIS-HF registry

This study aimed to investigate which proportion of patients with Heart Failure would be eligible for DAPA treatment in a real-world clinical practice.

Read full publication
Download Publication
Talk to an Expert
Data driving outcomes
For who
Technology
US log in
EU log in
Talk to an expert
Knowledge Center
Research publication: Direct anterior approach for total hip arthroplasty using the “bikini incision”
Real life use-cases: The value of Real-World evidence in Heart Failure for hospitals and life sciences explained
Unlocking Real-World evidence from a nationwide registry: use case and potential of the national histo-cytopathology registery (PALGA)
Contact
Stay in the know. Subscribe to our newsletter.
All rights reserved. Lynxcare Inc. | 530 7th Avenue - Suite 902 New York, NY 10018 USA

Download the research abstract

This study aimed to investigate which proportion of patients with Heart Failure would be eligible for DAPA treatment in a real-world clinical practice.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.